Skip to search formSkip to main contentSkip to account menu

icatibant Prefilled Syringe [Firazyr]

National Institutes of Health

Related topics

Related topics

2 relations

Narrower (1)

3 ML icatibant 10 MG/ML Prefilled Syringe [Firazyr]
Prefilled Syringe

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
ACE inhibitor related angioedema: a case report and brief review
2014
2014
Self-Administration Of a Novel Subcutaneous Bradykinin B2 Receptor Antagonist, Icatibant (Firazyr®), As An Effective Treatment Option In Patients With Hereditary Angioedema (HAE)
2014
2014
Icatibant, Firazyr® : indications actuelles et utilisations potentielles
L'icatibant, developpe sous le nom de HOE-140 et commercialise sous la designation de Firazyr®, est le premier antagoniste du… 
Review
2013
Review
2013
Angioödeme der Kopf-Hals-Region
ZusammenfassungDas Angioödem ist eine akute ödematöse Schwellung tieferer Hautschichten. Bei Manifestationen im Bereich der… 
2012
2012
PSY27 A Cost-Effectiveness Comparison of Icatibant and C1-Esterase Inhibitor Concentrate for the Symptomatic Treatment of Acute Attacks of Types I and II Hereditary Angioedema in the UK Setting
2011
2011
PND31 A Modelled Economic Evaluation of Firazyr® (Icatibant) for Symptomatic Treatment of Acute Attacks of Hereditary Angioedema (HAE) in Adults with C1-Esterase-Inhibitor (C1-INH) Deficiency
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)